SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-025379
Filing Date
2022-09-23
Accepted
2022-09-23 06:15:16
Documents
12
Period of Report
2022-09-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20220923.htm   iXBRL 8-K 96145
  Complete submission text file 0001628280-22-025379.txt   242326

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20220923.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20220923_lab.xml EX-101.LAB 23892
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20220923_pre.xml EX-101.PRE 12600
6 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20220923_htm.xml XML 10871
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 221260570
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences